Rac1 Regulates Peptidoglycan-induced Nuclear Factor-kappaB Activation and Cyclooxygenase-2 Expression in RAW 264.7 Macrophages by Activating the Phosphatidylinositol 3-kinase/Akt Pathway
Overview
Molecular Biology
Authors
Affiliations
Previously, we found that peptidoglycan (PGN), a cell wall component of the gram-positive bacterium Staphylococcus aureus, may activate the Ras/Raf-1/extracellular signal-regulated kinase (ERK) pathway, which in turn initiates IkappaB kinases alpha/beta (IKKalpha/beta) and nuclear factor-kappaB (NF-kappaB) activation, and ultimately induces cyclooxygenase-2 (COX-2) expression in RAW 264.7 macrophages. In this study, we further investigated the roles of Rac1, phosphatidylinositol 3-kinase (PI3K), and Akt in PGN-induced NF-kappaB activation and COX-2 expression in RAW 264.7 macrophages. PGN-induced COX-2 expression was attenuated by a Rac1 dominant negative mutant (RacN17), PI3K inhibitors (wortmannin and LY 294002), and an Akt inhibitor (1L-6-hydroxymethyl-chiro-inositol2-[(R)-2-O-methyl-3-O-octadecylcarbonate]). PGN-induced PGE(2) release was also inhibited by RacN17. Treatment of RAW 264.7 macrophages with PGN caused the activation of Rac and Akt. PGN-induced Akt activation was inhibited by RacN17, LY 294002, and the Akt inhibitor. Stimulation of RAW 264.7 macrophages with PGN resulted in an increase in IKKalpha/beta phosphorylation and p65 Ser536 phosphorylation; these effects were inhibited by RacN17, LY 294002, an Akt inhibitor, and an Akt dominant negative mutant (AktDN). The PGN-induced increases in kappaB-luciferase activity were also inhibited by RacN17, wortmannin, LY 294002, an Akt inhibitor, and AktDN. Treatment of macrophages with PGN induced the recruitment of p85alpha and Rac1 to Toll-like receptor 2 (TLR2) in a time-dependent manner. These results indicate that PGN may activate the Rac1/PI3K/Akt pathway through the recruitment of p85alpha and Rac1 to TLR2 to mediate IKKalpha/beta activation and p65 phosphorylation, which in turn induces NF-kappaB transactivation, and ultimately causes COX-2 expression in RAW 264.7 macrophages.
Wu Q, Chen S, Xie X, Yan H, Feng X, Su G J Neurooncol. 2025; .
PMID: 40019712 DOI: 10.1007/s11060-024-04934-6.
Zhang H, Ge S, Diao F, Song W, Zhang Y, Zhuang P Pharm Biol. 2023; 61(1):1512-1524.
PMID: 38069658 PMC: 11001279. DOI: 10.1080/13880209.2023.2287658.
Fu H, Zhang P, Zhao X, Zhong X Cell Death Dis. 2023; 14(9):619.
PMID: 37735499 PMC: 10514032. DOI: 10.1038/s41419-023-06150-y.
sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae.
Li H, Bradbury J, Edin M, Graves J, Gruzdev A, Cheng J J Clin Invest. 2021; 131(22).
PMID: 34591792 PMC: 8592545. DOI: 10.1172/JCI129679.
Ren B, Tan L, Xiong Y, Ji W, Mu J, Pei Y Evid Based Complement Alternat Med. 2020; 2020:9768414.
PMID: 32419835 PMC: 7204321. DOI: 10.1155/2020/9768414.